Introduction: Pituitary metastases are rare and difficult to diagnose. Their optimal approach and management remains to be defined.
Case Report: We report the case of a 56-year-old patient suffering from squamous cell lung carcinoma who developed pituitary metastasis with secondary hypopituitarism, the symptoms of which were initially attributed to depression.
Conclusion: Pituitary metastases can be difficult to diagnose, which may lead to delays in care, which can be fatal.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rmr.2014.11.071 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical confocal laser endomicroscopy for imaging of autofluorescence signals of human brain tumors and non-tumor brain.
J Cancer Res Clin Oncol
December 2024
Department of Neurosurgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Purpose: Analysis of autofluorescence holds promise for brain tumor delineation and diagnosis. Therefore, we investigated the potential of a commercial confocal laser scanning endomicroscopy (CLE) system for clinical imaging of brain tumors.
Methods: A clinical CLE system with fiber probe and 488 nm laser excitation was used to acquire images of tissue autofluorescence.
GH-Secreting Adenoma or Tumor? Issues in Pituitary Neoplasms Nomenclature, Classification, and Characterization.
Front Horm Res
November 2024
School of Medicine, University of Bologna, Bologna, Italy.
Article Synopsis
- - Acromegaly is a rare condition caused by excessive growth hormone secretion, typically from a pituitary adenoma, leading to high levels of insulin-like growth factor 1 and various severe health issues.
- - Pituitary adenomas (PAs) show a wide range of clinical and biological characteristics and can behave aggressively, making them challenging to classify and treat effectively over time.
- - The latest WHO Classification categorizes GH-secreting PAs into different types based on hormonal features, but more research is needed to better understand their behavior and improve treatment strategies through precision medicine.
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.
Acta Neuropathol
November 2024
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Article Synopsis
- Aggressive pituitary neuroendocrine tumors (PitNETs) often grow despite treatment and can metastasize, making them particularly challenging to manage.
- This study analyzed tumor samples from 64 patients to investigate genetic markers, finding distinct patterns between aggressive/metastatic tumors and benign ones through genome-wide methylation and chromosomal analyses.
- The results indicate potential biomarkers that could help in identifying high-risk patients earlier, refining treatment protocols, and improving outcomes for those with aggressive pituitary tumors.
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53.
Endocr Pathol
December 2024
Department of Pathology, University of California San Francisco (UCSF), 505 Parnassus Avenue, Room M-559, San Francisco, CA, 94143, USA.
High-grade or grade 3 epithelial neuroendocrine neoplasms (G3 NEN) are now divided into grade 3 well-differentiated neuroendocrine tumor (G3 NET) and neuroendocrine carcinoma (NEC), both defined by Ki-67 > 20% and/or > 20 mitoses per 2 mm. NET and NEC are thought to be distinct tumors with different genetic profiles: NEC classically harbors co-alteration of TP53 and RB1, whereas NET genetics are site-dependent with frequent alterations in MEN1, ATRX, DAXX, and TSC1/2 in pancreatic NETs. Progression from NET to NEC is considered rare and is not well described.
View Article and Find Full Text PDFSolitary pituitary metastasis from breast cancer masquerading as a pituitary macroadenoma: a report of 2 rare cases.
Gland Surg
October 2024
Laboratory of Cellular and Molecular Biology, School of Basic Medicine, Central South University, Changsha, China.
Background: Breast cancer is one of the most common malignant tumors, occurring in the mammary glands, which often metastasizes to bones, lungs, and liver. However, pituitary metastasis (PM) originating from breast cancer is a rare phenomenon that can easily be mistaken for benign pituitary macroadenoma.
Case Description: This report details two cases of middle-aged and elderly Chinese women who presented with serious neurological symptoms, each with a history of breast malignancy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!